| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Acetyl-L-carnitine ineffective in treatment of CIPN
|
Granovetter, Michael
|
|
2013
|
14 |
8 |
p. e299-
1 p.
|
article
|
| 2 |
Advances in MAGE-A3 immunotherapy
|
Baker, Holly
|
|
2013
|
14 |
8 |
p. e297-
1 p.
|
article
|
| 3 |
Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial
|
Tannock, Ian F
|
|
2013
|
14 |
8 |
p. 760-768
9 p.
|
article
|
| 4 |
A new approach to second-line therapy for urothelial cancer?
|
Sonpavde, Guru
|
|
2013
|
14 |
8 |
p. 682-684
3 p.
|
article
|
| 5 |
2013 ASCO Annual Meeting
|
Smith, Lan-Lan
|
|
2013
|
14 |
8 |
p. 686-687
2 p.
|
article
|
| 6 |
Assessment of volumetric growth rates of small colorectal polyps with CT colonography: a longitudinal study of natural history
|
Pickhardt, Perry J
|
|
2013
|
14 |
8 |
p. 711-720
10 p.
|
article
|
| 7 |
Breast cancer progression slowed by entinostat
|
Baker, Holly
|
|
2013
|
14 |
8 |
p. e298-
1 p.
|
article
|
| 8 |
Cancer in Botswana: resources and opportunities
|
Suneja, Gita
|
|
2013
|
14 |
8 |
p. e290-e291
nvt p.
|
article
|
| 9 |
Challenges imposed by the complexity of cancer genome
|
Ajani, Jaffer A
|
|
2013
|
14 |
8 |
p. e291-e292
nvt p.
|
article
|
| 10 |
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial
|
Vermorken, Jan B
|
|
2013
|
14 |
8 |
p. 697-710
14 p.
|
article
|
| 11 |
Daunorubicin is less toxic than idarubicin in paediatric AML
|
Baker, Holly
|
|
2013
|
14 |
8 |
p. e295-
1 p.
|
article
|
| 12 |
Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis
|
Mitchell, Alex J
|
|
2013
|
14 |
8 |
p. 721-732
12 p.
|
article
|
| 13 |
Digital cancer pathology in Africa
|
Dimaras, Helen
|
|
2013
|
14 |
8 |
p. e289-e290
nvt p.
|
article
|
| 14 |
Duration of trastuzumab for HER2-positive breast cancer
|
Montemurro, Filippo
|
|
2013
|
14 |
8 |
p. 678-679
2 p.
|
article
|
| 15 |
EGFR-directed treatments in SCCHN
|
Vokes, Everett E
|
|
2013
|
14 |
8 |
p. 672-673
2 p.
|
article
|
| 16 |
Extracranial rhabdoid tumours: what we have learned so far and future directions
|
Brennan, Bernadette
|
|
2013
|
14 |
8 |
p. e329-e336
nvt p.
|
article
|
| 17 |
FASTACT-2: but don't act too fast
|
Hirsch, Fred R
|
|
2013
|
14 |
8 |
p. 684-685
2 p.
|
article
|
| 18 |
Genes cannot be patented, US Supreme Court rules
|
Granovetter, Michael
|
|
2013
|
14 |
8 |
p. e301-
1 p.
|
article
|
| 19 |
Has targeted therapy for melanoma made chemotherapy obsolete?
|
Gibney, Geoffrey T
|
|
2013
|
14 |
8 |
p. 676-677
2 p.
|
article
|
| 20 |
Increased risk of bankruptcy for patients with cancer
|
Burki, Talha Khan
|
|
2013
|
14 |
8 |
p. e294-
1 p.
|
article
|
| 21 |
Integrated 2D and 3D mammography
|
Sumkin, Jules H
|
|
2013
|
14 |
8 |
p. e292-e293
nvt p.
|
article
|
| 22 |
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial
|
Wu, Yi-Long
|
|
2013
|
14 |
8 |
p. 777-786
10 p.
|
article
|
| 23 |
It doesn't stop at cure: monitoring childhood cancer survivors
|
The Lancet Oncology,
|
|
2013
|
14 |
8 |
p. 671-
1 p.
|
article
|
| 24 |
Lambrolizumab induces advanced melanoma regression
|
Burki, Talha Khan
|
|
2013
|
14 |
8 |
p. e297-
1 p.
|
article
|
| 25 |
Low-dose decitabine for myelodysplastic syndrome
|
Baker, Holly
|
|
2013
|
14 |
8 |
p. e299-
1 p.
|
article
|
| 26 |
Macmillan highlights failings in hospital care
|
Burki, Talha Khan
|
|
2013
|
14 |
8 |
p. e294-
1 p.
|
article
|
| 27 |
Mechanism of action of anthracycline drugs
|
Yaqub, Farhat
|
|
2013
|
14 |
8 |
p. e296-
1 p.
|
article
|
| 28 |
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial
|
Pivot, Xavier
|
|
2013
|
14 |
8 |
p. 741-748
8 p.
|
article
|
| 29 |
Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study
|
Ko, Yoo-Joung
|
|
2013
|
14 |
8 |
p. 769-776
8 p.
|
article
|
| 30 |
NICE guidance on bevacizumab in combination with gemcitabine and carboplatin for treating the first recurrence of platinum-sensitive advanced ovarian cancer
|
Pinilla-Dominguez, Pilar
|
|
2013
|
14 |
8 |
p. 691-692
2 p.
|
article
|
| 31 |
NICE guidance on bevacizumab in combination with paclitaxel and carboplatin for the first-line treatment of advanced ovarian cancer
|
Dyer, Matthew
|
|
2013
|
14 |
8 |
p. 689-690
2 p.
|
article
|
| 32 |
Nivolumab and ipilimumab therapy for advanced melanoma
|
Burki, Talha Khan
|
|
2013
|
14 |
8 |
p. e298-
1 p.
|
article
|
| 33 |
Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition
|
Burtness, Barbara
|
|
2013
|
14 |
8 |
p. e302-e309
nvt p.
|
article
|
| 34 |
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial
|
Seymour, Matthew T
|
|
2013
|
14 |
8 |
p. 749-759
11 p.
|
article
|
| 35 |
Personalisation of colorectal cancer screening
|
Gellad, Ziad
|
|
2013
|
14 |
8 |
p. 673-675
3 p.
|
article
|
| 36 |
Radiotherapy treatments for node-negative NPC
|
Granovetter, Michael
|
|
2013
|
14 |
8 |
p. e300-
1 p.
|
article
|
| 37 |
Recognition of surgical need as part of cancer control in Africa
|
Zogg, Cheryl K
|
|
2013
|
14 |
8 |
p. e289-
1 p.
|
article
|
| 38 |
Regulation of electronic cigarettes
|
Baker, Holly
|
|
2013
|
14 |
8 |
p. e301-
1 p.
|
article
|
| 39 |
Russia's legislation to ban smoking in public places
|
Yaqub, Farhat
|
|
2013
|
14 |
8 |
p. e295-
1 p.
|
article
|
| 40 |
SALL4, a new target in aggressive liver cancer
|
Gilbert, Judith A
|
|
2013
|
14 |
8 |
p. e300-
1 p.
|
article
|
| 41 |
Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised study
|
Robert, Caroline
|
|
2013
|
14 |
8 |
p. 733-740
8 p.
|
article
|
| 42 |
Subsequent neoplasms of the CNS among survivors of childhood cancer: a systematic review
|
Bowers, Daniel C
|
|
2013
|
14 |
8 |
p. e321-e328
nvt p.
|
article
|
| 43 |
Targeted therapy outperforms chemotherapy in NSCLC
|
Benmaamar, Ramla
|
|
2013
|
14 |
8 |
p. e296-
1 p.
|
article
|
| 44 |
18th Congress of the European Hematology Association
|
Brierley, Rob
|
|
2013
|
14 |
8 |
p. 688-
1 p.
|
article
|
| 45 |
The Cancer Chronicles
|
Burki, Talha Khan
|
|
2013
|
14 |
8 |
p. 695-696
2 p.
|
article
|
| 46 |
The Invisible Girls
|
Whinder, Frances
|
|
2013
|
14 |
8 |
p. 696-
1 p.
|
article
|
| 47 |
The legacy of cancer on depression and anxiety
|
Addington-Hall, Julia
|
|
2013
|
14 |
8 |
p. 675-676
2 p.
|
article
|
| 48 |
The Light That Shines
|
O'Donoghue, Odhran
|
|
2013
|
14 |
8 |
p. 694-695
2 p.
|
article
|
| 49 |
The X-HALE Awards: stubbing out youth smoking in Ireland
|
Cagney, Hannah
|
|
2013
|
14 |
8 |
p. 693-
1 p.
|
article
|
| 50 |
Tumour angiogenesis: an elusive target in castration-resistant prostate cancer
|
Galsky, Matthew D
|
|
2013
|
14 |
8 |
p. 681-682
2 p.
|
article
|
| 51 |
Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases
|
Sahgal, Arjun
|
|
2013
|
14 |
8 |
p. e310-e320
nvt p.
|
article
|
| 52 |
Will PICCOLO affect metastatic colorectal cancer therapy?
|
Eng, Cathy
|
|
2013
|
14 |
8 |
p. 679-680
2 p.
|
article
|
| 53 |
Workplace cancer screening
|
Marshall, Hilary
|
|
2013
|
14 |
8 |
p. 694-
1 p.
|
article
|
Journal description